Cen Biotech(OTC) CENBF

Market Cap$6.40K

Since IPO (2016)-100%

5 Year-100%

1 Year+0%

1 Month+0%

$0.00

+0%

+0.00Today

Cen Biotech last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-07-29

Cen Biotech stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-07-21
1 month	+0%	USD 0.00	2026-06-29
3 month	+0%	USD 0.00	2026-04-27
Year to date	+0%	USD 0.00	2025-12-31
1 year	+0%	USD 0.00	2025-07-28
3 year	-99.36%	USD 0.02	2023-07-28
5 year	-99.99%	USD 0.75	2021-07-30
Since inception	-99.99%	USD 1.98	2016-09-13

Cen Biotech Financials at a Glance

Market Cap

$6.40K

Revenue (TTM)

$619.83K

Net Income (TTM)

-$741.54K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

55.87 (High)

Dividend

$0.00

Beta (Volatility)

55.87 (High)

Price

$0.00

Volume

2,233

Open

$0.00

Price

$0.00

Volume

2,233

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Mar 31, 2023

Dividend

$0.00

Beta (Volatility)

55.87 (High)

Price

$0.00

Volume

2,233

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Mar 31, 2023

CENBF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cen Biotech

CEN Biotech, Inc. is a company focused on the development and production of LED lighting technology and hemp-based products. Established in 2013 and headquartered in Windsor, Canada, the company aims to cultivate hemp for various applications, including industrial, medical, and food sectors.

Products and Services

LED lighting technology for agricultural and industrial use
Hemp products for medical and food applications
Digital marketing and website development services

Growth Outlook

Recent quarterly revenue reached $65,233, showing potential for growth
Trailing twelve months (TTM) gross profit margin stands at 50.45%
Plans to expand hemp cultivation align with increasing market demand

Financial Highlights

Net income for Q3 2023 was $371,458, a significant improvement
Operating cash flow for Q3 2023 was $432,120, indicating positive cash generation
Current ratio is 0.025, highlighting liquidity challenges

CEN Biotech, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, with a focus on innovative solutions in lighting and hemp products. The company has shown a notable increase in revenue and net income in the most recent quarter, reflecting a positive trend in financial performance. The gross profit margin indicates effective cost management, while the operating cash flow suggests the company is generating cash from its operations. However, the current ratio indicates potential liquidity issues that may need addressing. Overall, CEN Biotech, Inc. presents an intriguing opportunity for investors interested in the growing sectors of hemp and sustainable technology.

AI Generated • Jul 30, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Brian S. Payne

Website

www.cenbiotechinc.com

Headquarters

Windsor, ON N8T 3R9, CA

CENBF Financials

Key Financial Metrics (TTM)

Gross Margin

50.45%

Operating Margin

-128.15%

Net Income Margin

-153.48%

Return on Equity

76.72%

Return on Capital

-43.09%

Return on Assets

-19.28%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.40K

Shares Outstanding

64.13M

Volume

2.23K

Avg. Volume

432.452

Financials (TTM)

Gross Profit

$422.00K

Operating Income

-$1.65M

EBITDA

-$387.09K

Operating Cash Flow

$670.17K

Capital Expenditure

-$281.22K

Free Cash Flow

$388.96K

Cash & ST Invst.

$419.60K

Total Debt

$4.98M

Cen Biotech Performance Analysis

Cen Biotech annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2021	2021-12-31	USD 626,867	N/A
2022	2022-12-31	USD 987,112	57.5%

Cen Biotech sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2022-12-31	127.3%
Q1	2023-03-31	-69.5%
Q2	2023-06-30	61.3%
Q3	2023-09-30	-57.0%

Cen Biotech annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2021	2021-12-31	USD -0.45	N/A
2022	2022-12-31	USD -0.02	-94.7%

Cen Biotech sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2022-12-31	-53.1%
Q1	2023-03-31	22.7%
Q2	2023-06-30	41.4%
Q3	2023-09-30	267.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2023YOY CHG

Revenue

$65.23K

-52.0%

Gross Profit

$65.23K

+200.3%

Gross Margin

100.00%

N/A

Market Cap

$6.40K

N/A

Market Cap/Employee

$1.60K

N/A

Employees

N/A

Net Income

$371.46K

+192.9%

EBITDA

$409.91K

+356.0%

Quarterly Fundamentals

Name

Q3 2023YOY CHG

Total Cash

$419.60K

+183.2%

Total Debt

$4.98M

+270.6%

Accounts Receivable

$114.74K

+151.3%

Inventory

$0.00

N/A

Long Term Debt

$121.87K

-35.9%

Short Term Debt

$4.85M

+321.2%

Return on Assets

-19.28%

N/A

Return on Invested Capital

59.82%

N/A

Free Cash Flow

$396.81K

+540.2%

Operating Cash Flow

$432.12K

+579.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

WOWUWOWI, Inc.

WOWUWOWI, Inc.$0.00+0.00%

SESISES Solar Inc.

SESISES Solar Inc.$0.00+0.00%

VIVXFAvivagen Inc.

VIVXFAvivagen Inc.$0.00+0.00%

UPPRUpper Street Marketing Inc.

UPPRUpper Street Marketing Inc.$0.00+0.00%

SPLMSentry Petroleum Ltd

SPLMSentry Petroleum Ltd$0.00+0.00%

MJNEMJ Holdings, Inc.

MJNEMJ Holdings, Inc.$0.00+0.00%

DNAGDNAPrint Genomics, Inc.

DNAGDNAPrint Genomics, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SOFISoFi Technologies

SOFISoFi Technologies$15.25-0.09%

INTCIntel

INTCIntel$81.88-0.05%

NVDANvidia

NVDANvidia$190.01-0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$57.75-0.06%

FFord Motor Company

FFord Motor Company$15.28+0.02%

NOKNokia

NOKNokia$8.41-0.06%

JBLUJetBlue Airways

JBLUJetBlue Airways$5.72-0.05%

Questions About CENBF

What is the current price of Cen Biotech?

Cen Biotech is trading at $0.00 per share.

What is the 52-week range for Cen Biotech?

Over the past 52 weeks, Cen Biotech has traded between $0.00 and $0.00.

How much debt does Cen Biotech have?

As of the most recent reporting period, Cen Biotech reported total debt of $5.23M.

How much cash does Cen Biotech have on hand?

Cen Biotech reported $83.60K in cash and cash equivalents in its most recent financial results.

What is Cen Biotech’s dividend yield?

Cen Biotech does not currently have a dividend yield.

Cen Biotech(OTC) CENBF

Cen Biotech Financials at a Glance

CENBF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cen Biotech

CENBF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cen Biotech Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CENBF

What is the current price of Cen Biotech?

What is the 52-week range for Cen Biotech?

How much debt does Cen Biotech have?

How much cash does Cen Biotech have on hand?

What is Cen Biotech’s dividend yield?

Premium Investing Services